Doroszko A, Janus A, Szahidewicz-Krupska E, Mazur G, Derkacz A (2016) Resistant hypertension. Adv Clin Exp Med 25:173–183. https://doi.org/10.17219/acem/58998

Article  PubMed  Google Scholar 

Drager LF, Genta PR, Pedrosa RP, Nerbass FB, Gonzaga CC, Krieger EM, Lorenzi-Filho G (2010) Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension. Am J Cardiol 105:1135–1139. https://doi.org/10.1016/j.amjcard.2009.12.017

Article  PubMed  Google Scholar 

Sjöström C, Lindberg E, Elmasry A, Hägg A, Svärdsudd K, Janson C (2002) Prevalence of sleep apnoea and snoring in hypertensive men: a population-based study. Thorax 57:602–607. https://doi.org/10.1136/thorax.57.7.602

Article  PubMed  PubMed Central  Google Scholar 

Calhoun DA, Nishizaka MK, Zaman MA, Harding SM (2004) Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 125:112–117. https://doi.org/10.1378/chest.125.1.112

Article  PubMed  Google Scholar 

Buffolo F, Li Q, Monticone S, Heinrich DA, Mattei A, Pieroni J, Mei M, Yang S, Hu YH, Yang MC, Sabbadin C, Pizzolo F, Giacchetti G, Fallo F, Veglio F, Reincke M, Wu VC, Mulatero P (2019) Primary aldosteronism and obstructive sleep apnea: a cross-sectional multi-ethnic study. Hypertension 74:1532–1540. https://doi.org/10.1161/HYPERTENSIONAHA.119.13349

Article  PubMed  Google Scholar 

Sheu JY, Chang LY, Chen JY, Chuang MH, Wu VC, Chueh JS (2024) The prevalence of obstructive sleep apnea in patients with primary aldosteronism. J Clin Endocrinol Metab 109:2681–2691. https://doi.org/10.1210/clinem/dgae390

Article  PubMed  Google Scholar 

Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF Jr (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2015-4061

Libianto R, Russell GM, Stowasser M, Gwini SM, Nuttall P, Shen J, Young MJ, Fuller PJ, Yang J (2022) Detecting primary aldosteronism in Australian primary care: a prospective study. Med J Aust 216:408–412. https://doi.org/10.5694/mja2.51456

Article  PubMed  Google Scholar 

Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, Gabetti L, Mengozzi G, Williams TA, Rabbia F, Veglio F, Mulatero P (2017) Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol 69:1811–1820. https://doi.org/10.1016/j.jacc.2017.01.052

Article  PubMed  Google Scholar 

Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F, PAPY Study Investigators (2006) A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48:2293–2300. https://doi.org/10.1016/j.jacc.2006.07.059

Article  PubMed  Google Scholar 

Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A (2018) Renal outcomes in medically and surgically treated primary aldosteronism. Hypertension 72:658–666. https://doi.org/10.1161/HYPERTENSIONAHA.118.11528

Article  PubMed  Google Scholar 

Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A (2018) Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism. JAMA Cardiol 3:768–774. https://doi.org/10.1001/jamacardio.2018.2003

Article  PubMed  PubMed Central  Google Scholar 

Jing Y, Liao K, Li R, Yang S, Song Y, He W, Wang K, Yang J, Li Q, Hu J (2021) Cardiovascular events and all-cause mortality in surgically or medically treated primary aldosteronism: a meta-analysis. J Renin Angiotensin Aldosterone Syst 22:14703203211000462. https://doi.org/10.1177/14703203211000462

Article  Google Scholar 

Kline GA, Pasieka JL, Harvey A, So B, Dias VC (2013) Medical or surgical therapy for primary aldosteronism: post treatment follow-up as a surrogate measure of comparative outcomes. Ann Surg Oncol 20:2274–2278. https://doi.org/10.1245/s10434-013-2897-0

Article  PubMed  Google Scholar 

Monticone S, D’Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, Mulatero P (2018) Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 6:41–50. https://doi.org/10.1016/S2213-8587(18)30055-6

Article  PubMed  Google Scholar 

Rossi GP, Rossitto G, Amar L, Azizi M, Riester A, Reincke M, Degenhart C, Widimsky J, Naruse M, Deinum J, Schultze Kool L, Kocjan T, Negro A, Rossi E, Kline G, Tanabe A, Satoh F, Rump LC, Vonend O, Willenberg HS, Fuller PJ, Yang J, Chee NYN, Magill SB, Shafigullina Z, Quinkler M, Oliveras A, Wu KD, Wu VC, Kratka Z, Barbiero G, Battistel M, Chang CC, Vanderriele PE, Pessina AC (2019) Clinical outcomes of 1625 patients with primary aldosteronism subtyped with adrenal vein sampling. Hypertension 74:800–808. https://doi.org/10.1161/HYPERTENSIONAHA.119.13291

Article  PubMed  Google Scholar 

Ma LQ, Song Y, Mei M, He WW, Hu JB, Cheng QF, Tang ZW, Luo T, Wang Y, Zhen QN, Wang ZH, Qing H, He YH, Li QF, Yang SM, Chongqing Primary Aldosteronism Study (CONPASS) Group (2018) Age-related cut offs of plasma aldosterone/renin concentration for primary aldosteronism screening. Int J Endocrinol 2018:8647026. https://doi.org/10.1155/2018/8647026

Article  PubMed  PubMed Central  Google Scholar 

Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro MC, Beuschlein F, Rossi GP, Nishikawa T, Morganti A, Seccia TM, Lin YH, Fallo F, Widimsky J (2020) Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the working group on endocrine hypertension of the European society of hypertension. J Hypertens 38:1919–1928. https://doi.org/10.1097/HJH.0000000000002510

Article  PubMed  Google Scholar 

Song Y, Yang S, He W, Hu J, Cheng Q, Wang Y, Luo T, Ma L, Zhen Q, Zhang S et al (2018) Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study. Hypertension 71:118–124. https://doi.org/10.1161/HYPERTENSIONAHA.117.105774

Article  PubMed  Google Scholar 

Thuzar M, Young K, Ahmed AH, Ward G, Wolley M, Guo Z, Gordon RD, McWhinney BC, Ungerer JP, Stowasser M (2020) Diagnosis of primary aldosteronism by seated saline suppression test: variability between immunoassay and HPLC-MS/MS. J Clin Endocrinol Metab 105:e477–e483. https://doi.org/10.1210/clinem/dgz240

Article  Google Scholar 

Tumor Endocrinology Group of Endocrinology and Metabolism Branch of Chinese Medical Doctor Association; Endocrine Hypertension Collaboration in China (2025) Expert consensus on the operation specifications and result interpretation of adrenal vein sampling. Chin J Endocrinol Surg 19:1–7. https://doi.org/10.3760/cma.j.cn115807-20250103-00003

Article  Google Scholar 

Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, Satoh F, Amar L, Quinkler M, Deinum J, Beuschlein F, Kitamoto KK, Pham U, Morimoto R, Umakoshi H, Prejbisz A, Kocjan T, Naruse M, Stowasser M, Nishikawa T, Young WF, Gomez-Sanchez CE, Funder JW, Reincke M (2017) Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 5:689–699. https://doi.org/10.1016/S2213-8587(17)30135-3

Article  PubMed  PubMed Central  Google Scholar 

Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, Marcus CL, Mehra R, Parthasarathy S, Quan SF, Redline S, Strohl KP, Davidson Ward SL, Tangredi MM (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM manual. J Clin Sleep Med 8:597–619. https://doi.org/10.5664/jcsm.2172

Article  PubMed  PubMed Central  Google Scholar 

Dobrowolski P, Kołodziejczyk-Kruk S, Warchoł-Celińska E, Kabat M, Ambroziak U, Wróbel A, Piekarczyk P, Ostrowska A, Januszewicz M, Śliwiński P, Lenders JWM, Januszewicz A, Prejbisz A (2021) Primary aldosteronism is highly prevalent in patients with hypertension and moderate to severe obstructive sleep apnea. J Clin Sleep Med 17:629–637. https://doi.org/10.5664/jcsm.9038

Article  PubMed  PubMed Central  Google Scholar 

Loh HH, Sukor N (2022) Primary aldosteronism and obstructive sleep apnea: what do we know thus far? Front Endocrinol 13:976979. https://doi.org/10.3389/fendo.2022.976979

Article  Google Scholar 

Wang Y, Li CX, Lin YN, Zhang LY, Li SQ, Zhang L et al (2022) The role of aldosterone in OSA and OSA-related hypertension. Front Endocrinol 12:801689. https://doi.org/10.3389/fendo.2021.801689

Article  Google Scholar 

Jin ZN, Wei YX (2016) Meta-analysis of effects of obstructive sleep apnea on the renin-angiotensin-aldosterone system. J Geriatr Cardiol 13:333–343. https://doi.org/10.11909/j.issn.1671-5411.2016.04.006

Article  PubMed  PubMed Central  Google Scholar 

Shimada H, Noro E, Suzuki S, Sakamoto J, Sato I, Parvin R et al (2020) Effects of adipocyte-derived factors on the adrenal cortex. Curr Mol Pharmacol 13:2–6. https://doi.org/10.2174/1874467213666191125150357

Article  PubMed  Google Scholar 

Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378–1384. https://doi.org/10.1056/NEJM200005113421901

Article  PubMed